Sort
21,281 grants matching “influenza”
Tissue resident memory T cells and chronic lung allograft dysfunction
$761,819Mark Eugene Snyder · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity
$761,818Martin S Zand · University Of Rochester · R01 · FY2017 · AI
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
$761,729Peter M Henson · National Jewish Health · R01 · FY2021 · HL
Alveolar epithelial glycocalyx resilience in women during ARDS
$761,615Eric Peter Schmidt · Massachusetts General Hospital · R01 · FY2025 · HL
Multivalent nanocluster universal influenza vaccine given by microneedle patch
$761,509Baozhong Wang · Georgia State University · R01 · FY2021 · AI
Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients
$761,370Guang-Shing Cheng · Fred Hutchinson Cancer Center · R01 · FY2023 · HL
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$761,361Peter G Szilagyi · University Of California Los Angeles · R01 · FY2020 · AI
Randomized controlled trial of a novel digital health solution to enable remote fetal monitoring in high risk pregnancies
$761,326Nadav Schwartz · University Of Pennsylvania · R01 · FY2021 · HD
Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial
$761,289William Martinez · Vanderbilt University Medical Center · R01 · FY2022 · DK
PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED
$761,059Robert Rodriguez · University Of California, San Francisco · R01 · FY2021 · AI
Tfh dysfunction in HIV and Aging
$761,028Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2020 · AG
Staphylococcal superantigen and anthrax inhibitors
$760,963Patrick M Schlievert · University Of Chicago · U54 · FY2011 · AI
The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD
$760,907Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$760,892Stephanie Jost · Duke University · R01 · FY2024 · AI
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$760,647Jennifer K Hoffman · Duke University · R01 · FY2024 · AI
Type 2 Inflammation and Remodeling Elicited Through an LTE4/OXGR1-dependent pathway
$760,583Nora Amanda Barrett · Brigham And Women'S Hospital · R01 · FY2024 · AI
Next-generation phenotypic antimicrobial susceptibility test platform: rapid results and comprehensive menus
$760,449Eric Stern · Selux Diagnostics, Inc. · R44 · FY2019 · AI
A Multi-Omics Approach to the Examination of Bacterial Co-pathogens
$760,314David A Rasko · University Of Maryland Baltimore · U19 · FY2020 · AI
Tfh dysfunction in HIV and Aging
$760,092Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2021 · AG
Countermeasures for Bioterroism Targeting Cellular Host Factors
$760,052John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2009 · AI
Countermeasures for Bioterroism Targeting Cellular Host Factors
$760,000John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2008 · AI
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$759,584Suresh K Mittal · Purdue University · R01 · FY2025 · AI
Influence of the nasal microbiome on host susceptibility and response to respiratory viruses
$759,454Cindy Liu · George Washington University · R01 · FY2023 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$759,381Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
Ecology-Based Risk Assessment and Early Warning for HPAI in Asia
$759,265Xiangming Xiao · University Of Oklahoma · R01 · FY2011 · TW